Tom De Ridder

4PUBLICATIONS
24CO-AUTHORS
Gene and molecular therapyBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 02, 2025
Intratumoural tigilanol tiglate in the multicentre treatment of equine sarcoids and cutaneous melanomas.

Raphael Labens, Corey Saba, Jarred Williams

|Sep 14, 2022
Topical, immunomodulatory epoxy-tiglianes induce biofilm disruption and healing in acute and chronic skin wounds.

Lydia C Powell, Jason K Cullen, Glen M Boyle

|Jan 13, 2021
Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate.

Paul Reddell, Thomas R De Ridder, John M Morton

|Jun 17, 2020
Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC-46).

Thomas R De Ridder, Justine E Campbell, Cheryl Burke-Schwarz

Pageof 1